UNMC Department of Pathology Microbiology and Immunology
Pathology trainees contribute to department’s research output
Recent publications and grants from PMI residents and predoctoral and postdoctoral trainees
Apr 14, 2026
Department announces grants, publications
Department researchers have been awarded six grants. In addition, our researchers’ work has generated 19 manuscript publications.
Apr 9, 2026
Two pathology trainees awarded scholarships to attend CAP leadership summit in Washington
Two house officers in UNMC’s Department of Pathology, Microbiology and Immunology have been awarded scholarships to attend the 2026 CAP Pathologists Leadership Summit.
Apr 8, 2026
Department announces grants, publications
Department researchers have been awarded two grants. In addition, our researchers’ work has generated nearly 30 manuscript publications.
Feb 10, 2026
Trainees contribute to department’s research output
Recent publications and grants from PMI residents and predoctoral and postdoctoral students.
Feb 10, 2026
IPID program welcomes new graduate students
The Immunology, Pathology & Infectious Disease (IPID) program hosted by UNMC’s Department of Pathology, Microbiology and Immunology added six graduate students for 2025-2026.
Oct 8, 2025
NPHL leaders are making news
Dr. Peter Iwen and Emily McCutchen authored or were featured in a number of recent publications.
Oct 8, 2025
Department announces grants, publications
Department faculty have been awarded seven grants. In addition, our researchers’ work has generated three dozen manuscript publications.
Oct 8, 2025
Department researchers publish paper on angioimmunoblastic T-cell lymphomas
Drs. Alyssa Bouska and Javeed Iqbal, in addition to more than a dozen other departmental investigators, recently published a paper on angioimmunoblastic T-cell lymphomas.
Aug 5, 2025
Department announces new publications
Research work by faculty and students in our department has generated nearly 30 manuscript publications. New publications (June 2025-current): Synergistic effects of HO-1 inhibition and chemotherapy on tumor proliferation and immune infiltration: An in vitro and in vivo approach to enhancing prostate cancer treatment.Salloom RJ, Sahtout DZ, Ahmad IM, Abdalla MY. Transl Oncol. 2025 Apr;54:102339. […]
Aug 5, 2025
